Dr. Nadine Geiser

Umiami is a French foodtech that was founded in 2020 with the mission to reduce worldwide meat consumption and its impact on health, animals, and the environment. We are pioneers in the development of a patent-pending process for texturizing plant proteins called "umisation". With our umisation technology, we can recreate the meat and fish fillet experience without compromising on taste and texture. After opening our first pilot plant innovation center last year, Umiami will inaugurate its first large-scale production plant in October 2023. The 14,000m2 site is located in Duppigheim, France, close to the German border, and will have a production capacity of 7,500 tonnes per year with one production line. Umiami is now fully ready to offer its first 100% plant-based chicken fillet to food processing and catering companies.

Dairy production is currently hugely unsustainable and also highly inefficient. At Better Dairy we are using precision fermentation to produce the same cheeses, yoghurts, ice creams that customers currently enjoy without having to use animals.

Luya is a flavor loaded alternative to meat that doesn’t try to be meat. We rescue organic okara - a by-product of tofu and soy milk production of which more than 14 million tonnes go to waste globally every year - and turn it into ready-to-cook slices, chunks and patties. Leveraging the power of mycelium fermentation, we can skip all the additives and highly processed ingredients, and offer 100% natural and organic deliciousness made in Switzerland.

Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.

Infinite Roots® We are Infinite Roots®—a biotech company using fermentation and fungi to create the next generation of sustainable alternative proteins. We believe in a food system that provides accessible, tasty, and nutritious food for everyone while preserving our planet. We are a team of 60 people, from 25 different countries, speaking 15 different languages. To solve global issues, you need minds from around the world! Follow us and watch fungi and food-tech transform the food system!

Memo Therapeutics AG (“MTx”) is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer. The Company’s lead program, Potravitug, is in Phase II development targeting BK viremia (BKV) in kidney transplant recipients, an infection which can result in decreased kidney functionality and longevity and reduced patient survival. Potravitug has the potential to become the best and first-in-class BKV disease-modifying therapy for kidney transplant patients. Alongside Potravitug, MTx is focused on discovering novel antibody-target pairs for oncology based on tumor infiltrating B-cells derived leveraging tertiary lymphoid structure biology. The Company has a partnership in place with Ono Pharmaceutical for two oncology targets. Underpinning MTx’s core assets is its proprietary DROPZYLLA® technology, an antibody repertoire copying engine with high-throughput screening capabilities. MTx is a private company located in Schlieren / Zurich and backed by investors including Ysios Capital, Kurma Partners, Pureos Bioventures, Swisscanto, Vesalius Biocapital and Adjuvant Capital.

Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data.

We help to decarbonise the global economy. As a climate tech VC, we are driven by tackling the climate crisis and only invest in technologies with scalable businesses and significant emissions savings potential. We support startups from early to growth stage, focusing on Energy, Food and Agriculture, Manufacturing, Buildings, and Mobility. Entrepreneurs who understand decarbonisation as a value driver are whom we back; those who think big, act macro; those who build tech for a regenerative world.

Umiami is a French foodtech that was founded in 2020 with the mission to reduce worldwide meat consumption and its impact on health, animals, and the environment. We are pioneers in the development of a patent-pending process for texturizing plant proteins called "umisation". With our umisation technology, we can recreate the meat and fish fillet experience without compromising on taste and texture. After opening our first pilot plant innovation center last year, Umiami will inaugurate its first large-scale production plant in October 2023. The 14,000m2 site is located in Duppigheim, France, close to the German border, and will have a production capacity of 7,500 tonnes per year with one production line. Umiami is now fully ready to offer its first 100% plant-based chicken fillet to food processing and catering companies.

redalpine is the pan-European venture capital firm that empowers GameChangers. Founded in Switzerland in 2006, redalpine brings together financial investment, operational expertise, and a vast international network to help ambitious entrepreneurs transform their vision into a reality. With over €1bn in assets under management and a disciplined, sector-agnostic investment strategy, the firm has backed some of Europe’s most disruptive companies, including N26, Mistral AI, Proxima Fusion, Klarna, Taxfix, Inkitt, 9fin, and vivenu. redalpine has over 100 companies in its portfolio and invests Europe-wide from its offices in Zurich, Berlin, and London.

Dairy production is currently hugely unsustainable and also highly inefficient. At Better Dairy we are using precision fermentation to produce the same cheeses, yoghurts, ice creams that customers currently enjoy without having to use animals.

Luya is a flavor loaded alternative to meat that doesn’t try to be meat. We rescue organic okara - a by-product of tofu and soy milk production of which more than 14 million tonnes go to waste globally every year - and turn it into ready-to-cook slices, chunks and patties. Leveraging the power of mycelium fermentation, we can skip all the additives and highly processed ingredients, and offer 100% natural and organic deliciousness made in Switzerland.